SGLT2 inhibitor and incretin mimetic therapy for type 2 diabetes and chronic kidney disease.

Publication Title

Lancet Diabetes Endocrinol

Authors

Katherine Tuttle, Providence Medical Research CenterFollow

Document Type

Article

Publication Date

6-1-2019

Clinical Institute

Kidney & Diabetes

Specialty/Research Institute

Nephrology

Specialty/Research Institute

Endocrinology